🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety, tolerability, and efficacy of tedizoli...
Status
Completed
Location
Rady Children's Hospital-San Diego ( Site 0118)
Start Date
2019-01-20
Trial ID
NCT03176134
Treatments Being Tested
The purpose of the study is to compare the safety of intravenous (IV) and/o...
Status
Completed
Location
Multiple Locations
Start Date
2015-03-25
Trial ID
NCT02276482
Treatments Being Tested
This study proposes to: 1. Characterize the impact of oral vancomycin on C...
Status
Completed
Location
Medical College of Wisconsin, Inc.
Start Date
2019-07-17
Trial ID
NCT03827447
Treatments Being Tested
The purpose of this study is to determine whether ceftaroline is effective ...
Status
Completed
Location
Investigational Site
Start Date
2012-10
Trial ID
NCT01645735
Treatments Being Tested
Segments 2A and 2B of this trial evaluate the safety, efficacy, pharmacokin...
Status
Completed
Location
Acurx Site #118: Dr Janet Reiser
Start Date
2020-03-06
Trial ID
NCT04247542
Treatments Being Tested
The purpose of this research is to evaluate the primary objectives of safet...
Status
Completed
Location
131
Start Date
2021-01-05
Trial ID
NCT04781387
Treatments Being Tested
The primary object is to compare the early clinical efficacy (after 48-72 h...
Status
Completed
Location
Durata Clinical Site
Start Date
2011-07
Trial ID
NCT01431339
Treatments Being Tested
The purpose of this study is to determine whether ceftaroline is effective ...
Status
Completed
Location
Investigational Site
Start Date
2007-03
Trial ID
NCT00423657
Treatments Being Tested
To determine the safety and descriptive efficacy of dalbavancin for the tre...
Status
Completed
Location
University of South Alabama /ID# 237446
Start Date
2017-03-30
Trial ID
NCT02814916
Treatments Being Tested
The primary object is to compare the early clinical efficacy (after 48-72 h...
Status
Completed
Location
Durata Study Site
Start Date
2011-03
Trial ID
NCT01339091
Treatments Being Tested